BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao D, Li Z, Liu X, Liu N, Bao X, Sun H, Meng Q, Ren H, Bai J, Zhou X, Tang L. Lymphocyte expression of EZH2 is associated with mortality and secondary infectious complications in sepsis. Int Immunopharmacol 2020;89:107042. [PMID: 33068867 DOI: 10.1016/j.intimp.2020.107042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yue D, Wang Z, Yang Y, Hu Z, Luo G, Wang F. EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders. Exp Ther Med 2021;21:437. [PMID: 33747174 DOI: 10.3892/etm.2021.9854] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abhimanyu, Ontiveros CO, Guerra-Resendez RS, Nishiguchi T, Ladki M, Hilton IB, Schlesinger LS, DiNardo AR. Reversing Post-Infectious Epigenetic-Mediated Immune Suppression. Front Immunol 2021;12:688132. [PMID: 34163486 DOI: 10.3389/fimmu.2021.688132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]